Clinical Trials in Los Angeles

Showing 2081-2100 of 8,055 trials

Reducing Blood Pressure in Patients With High Cardiovascular Risk

NCT05937685

BP-REACH is a study of a team-based (pharmacist and health coach) program for lowering blood pressure for people with a prior stroke or heart attack in the Los Angeles Department of Health Services healthcare system. The goal of this clinical trial is to test if this team based program is better at helping people reduce their blood pressure than usual care for people with prior heart attack or stroke. The main questions it aims to answer are: * Do people in the REACH BP program have lower blood pressure at 12 months compared to those getting usual care? * Do people in the REACH BP program have better Life's Essential 8 scores and patient experience compared to those getting usual care?

Myocardial InfarctionHypertensionStroke

University of Southern California546 participantsStarted Sep 2023

Downey, California, United States • Los Angeles, California, United States • Sylmar, California, United States +1 more locations

COMPLETEDNA< 1 mile

STEM-Parkinson's Disease

NCT04797611

This is a double-blinded, controlled, and randomized clinical trial (RCT) to establish the safety and efficacy of a non-invasive neuromodulation device for treating symptoms associated with Parkinson's disease.

Parkinson DiseaseParkinson's Disease and Parkinsonism

Scion NeuroStim188 participantsStarted May 2022

Scottsdale, Arizona, United States • Los Angeles, California, United States • Englewood, Colorado, United States +20 more locations

Reducing Blood Pressure in Patients With High Cardiovascular Risk

STEM-Parkinson's Disease

Find Trials by Condition in Los Angeles

Brain Health in Breast Cancer Survivors

Hemi-Gland Cryoablation for Prostate Cancer at UCLA

Multicenter Randomized Trial of 68Ga-PSMA-11 PET/CT Based SRT After Radical Prostatectomy

A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell Transplant

Women's Heart Attack Research Program: Stress Ancillary Study

A Study of SEA-CD40 Given With Other Drugs in Cancers

Affect Treatment for Depression and Anxiety (TAD Pilot)

Motion Sifnos: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness

A Study Assessing KB304 for the Treatment of Wrinkles in Women

A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) for the Treatment of Superficial Skin Depressions

Extension Study to Evaluate the Long-Term Outcomes of Pediatric Patients Who Received Treatment for Retinopathy of Prematurity in the VGFTe-ROP-1920 Study (Acronym: Butterfleye Next)

Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC

The Percutaneous Transmural Arterial Bypass -1 Study (Post Approval Registry)

Tornier Shoulder Outcomes Study to Examine Safety and Functional Outcomes in Shoulder Arthroplasty and Fracture Patients

Adalimumab in JIA-associated Uveitis Stopping Trial

QT Changes as Detected From LINQ ECG During Antiarrhythmic Loading (LINQ QT)

SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma

Changing the Paradigm of In-Hospital Cardiopulmonary Resuscitation